Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Farmers Insurance
Queensland Health
Harvard Business School

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:Methods for the treatment or inhibition of ileus
Abstract: Methods for the treatment of ileus are disclosed wherein the peripheral mu opioid antagonist methylnaltrexone is administered.
Inventor(s): Farrar; John J. (Chester Springs, PA), Schied; Peter J. (Southampton, PA), Schmidt; William K. (Newark, DE), Carpenter; Randall L. (Waban, MA)
Assignee: Adolor Corporation (Exton, PA)
Filing Date:Jun 13, 2002
Application Number:10/171,299
Claims:1. A method of treating or inhibiting ileus comprising administering to a patient an effective amount of a peripheral mu opioid antagonist compound, wherein said peripheral mu opioid antagonist compound is the quaternary morphinan compound N-methylnaltrexone.

2. A method according to claim 1 wherein the ileus is selected from the group consisting of postsurgical ileus and postpartum ileus.

3. A method according to claim 2 wherein the ileus is post-surgical ileus.

4. A method according to claim 3 wherein said postsurgical ileus is postsurgical paralytic ileus.

5. A method according to claim 1 wherein the ileus is ileus of the colon.

6. A method according to claim 1 wherein the ileus occurs in the absence of exogenous opioid agonists.

7. A method according to claim 1 further comprising administering an opiate or an opioid to said patient.

8. A method according to claim 7 wherein said opiate or opioid comprises an opioid analgesic.

9. A method according to claim 8 wherein said opioid analgesic comprises a mu opioid agonist.

10. A method according to claim 1 further comprising administering to said patient a compound which slows gut motility.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
US Army
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus